81209 Blm gene
Also known as: BLM gene testing, Bloom syndrome screening
Molecular analysis of the BLM gene to identify mutations associated with Bloom syndrome, a hereditary cancer predisposition syndrome.
In Plain Language
cancer susceptibility gene test; genetic immune disorder screening
Clinical Context
Ordered to diagnose Bloom syndrome in individuals with growth deficiency, immunodeficiency, and cancer predisposition.
RVU Information
CPT 81209 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81209?
CPT 81209 (Blm gene) is a Pathology & Lab code. Molecular analysis of the BLM gene to identify mutations associated with Bloom syndrome, a hereditary cancer predisposition syndrome.
Who uses CPT code 81209?
CPT 81209 is used by Genetics, Oncology, Pathology. Ordered to diagnose Bloom syndrome in individuals with growth deficiency, immunodeficiency, and cancer predisposition.
When is CPT 81209 used?
Ordered to diagnose Bloom syndrome in individuals with growth deficiency, immunodeficiency, and cancer predisposition.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.